TickerFacts.

Tonix Pharmaceuticals Holding Corp. (TNXP): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-32, first reflected in a filing dated 2022-08-08; 1-for-6, first reflected in a filing dated 2023-11-09; 1-for-100, first reflected in a filing dated 2025-08-11. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

12.79M
As of 2025-12-31
16.79M
As of 2026-06-30
206.01M2010-12-31: 18.03M2011-12-31: 1.35M2012-12-31: 2.16M2013-12-31: 5.82M2014-12-31: 10.81M2015-12-31: 1.88M2016-12-31: 3.92M2017-12-31: 785.9K2018-12-31: 328.7K2019-12-31: 8.53M2020-12-31: 206.01M2021-12-31: 15.64M2022-12-31: 12.37M2023-12-31: 20.9K2024-12-31: 4.39M2025-12-31: 12.79M12.79M
2010-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-3112.79M+191.6%2026-03-12, Balance as of period end
2024-12-314.39Mn/c2026-03-12, Balance as of period end
2023-12-3120.9K-99.8%2025-03-18, Balance as of period end
2022-12-3112.37Mn/c2024-04-01, Balance as of period end
2021-12-3115.64Mn/c2023-03-13, Balance as of period end
2020-12-31206.01Mn/m2022-03-14, Balance as of period end
2019-12-318.53Mn/m2021-03-15, Balance as of period end
2018-12-31328.7K-58.2%2020-03-24, Balance as of period end
2017-12-31785.9Kn/c2019-03-18, Balance as of period end
2016-12-313.92Mn/c2018-03-09, Balance as of period end
2015-12-311.88M-82.6%2017-04-13, Balance as of period end
2014-12-3110.81M+85.6%2016-03-03, Balance as of period end
2013-12-315.82M+169.7%2015-02-27, Balance as of period end
2012-12-312.16M+59.5%2014-03-28, Balance as of period end
2011-12-311.35M-92.5%2013-11-22, Balance as of period end
2010-12-3118.03Mn/a2012-03-30, Balance as of period end